CEO
Esham Strategies LLC
Cartier Esham, is the CEO of Esham Strategies, a strategic consultancy firm in D.C. that works to empower thought leadership, disrupt the status quo and advance innovative health policy solutions. She also represents the Alliance for a Stronger FDA and serves as the organization’s Executive Director.
Prior to launching her own firm, she served as the serves as the Chief Scientific Officer at the Biotechnology Innovation Organization (BIO) where she managed and directed BIO’s policy development, advocacy, research and educational initiatives for BIO’s emerging companies team, the science and regulatory team, the infectious disease team, the industry analysis and research team, and the membership team.
Dr. Esham has over 20 years of health policy experience. Prior to joining BIO, Dr. Esham was a Vice President and Director of Research at Dutko Worldwide, a private consulting firm in Washington D.C., where she worked on a variety of environmental, education, science, technology, and health care related issues on the federal, state, and local levels. Dr. Esham has a Ph.D. in Microbiology from the University of Georgia, a master’s degree in Marine Biology from the University of North Carolina at Wilmington and a bachelor’s degree from the University of Kentucky.
FDA Forecast: What the FDA has Planned in 2026 for Pharmaceuticals and Biotechnology Products
Wednesday, October 8, 2025
2:15 PM - 3:15 PM EST